What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
Aldo Scarpa spends much of his time researching Pathology, Cancer research, Pancreatic cancer, Internal medicine and Pancreas.
His Pathology research is multidisciplinary, incorporating elements of Gene mutation and Loss of heterozygosity.
Aldo Scarpa interconnects Carcinogenesis, Cancer, Gene, Mutation and MEN1 in the investigation of issues within Cancer research.
His Carcinogenesis study integrates concerns from other disciplines, such as Regulation of gene expression, microRNA and Gene expression profiling.
He has researched Pancreatic cancer in several fields, including Cell culture, Immunology, Confidence interval, Molecular biology and KRAS.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Endocrinology, Oncology and General surgery.
His most cited work include:
- A microRNA expression signature of human solid tumors defines cancer gene targets (4837 citations)
- International network of cancer genome projects (1611 citations)
- Genomic analyses identify molecular subtypes of pancreatic cancer (1396 citations)
What are the main themes of his work throughout his whole career to date?
Aldo Scarpa mainly focuses on Internal medicine, Cancer research, Pathology, Oncology and Pancreatic cancer.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Endocrinology.
His Cancer research study incorporates themes from Carcinogenesis, Cancer, Adenocarcinoma, Cell growth and Neuroendocrine tumors.
In his study, which falls under the umbrella issue of Pathology, Pancreatic tumor and Radiology is strongly linked to Pancreas.
His work carried out in the field of Oncology brings together such families of science as Colorectal cancer, Microsatellite instability and Pancreatic ductal adenocarcinoma.
His Pancreatic cancer study frequently draws connections between adjacent fields such as Immunology.
He most often published in these fields:
- Internal medicine (34.20%)
- Cancer research (27.93%)
- Pathology (24.52%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (27.93%)
- Internal medicine (34.20%)
- Pancreatic cancer (20.71%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cancer research, Internal medicine, Pancreatic cancer, Oncology and Cancer.
His biological study spans a wide range of topics, including Cancer cell, Immune system, KRAS, Gene and Metastasis.
His Internal medicine study frequently intersects with other fields, such as Gastroenterology.
He combines subjects such as Epithelial–mesenchymal transition, Medullary carcinoma, Pancreas and Adenosquamous carcinoma with his study of Pancreatic cancer.
His study explores the link between Pancreas and topics such as Pathology that cross with problems in Heterogeneous group and Intraductal papillary mucinous neoplasm.
His Oncology research includes elements of Precision medicine, Microsatellite instability, DNA sequencing and DNA mismatch repair.
Between 2018 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach (120 citations)
- Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group. (57 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His scientific interests lie mostly in Cancer research, Pancreatic cancer, Internal medicine, Oncology and Cancer.
His research integrates issues of Cancer cell, Survival rate, CD8, Immune system and Metastasis in his study of Cancer research.
Aldo Scarpa has included themes like Odds ratio, Meta-analysis, Pathology and KRAS in his Pancreatic cancer study.
Aldo Scarpa focuses mostly in the field of Pathology, narrowing it down to matters related to Prostaglandin E synthase and, in some cases, Cyst.
His studies in Internal medicine integrate themes in fields like Single-nucleotide polymorphism and Type 2 Diabetes Mellitus.
His Cancer research integrates issues from PI3K/AKT/mTOR pathway, PTEN, Radiology and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
